When an Antidepressant Is Prescribed for Sleep

Why an antidepressant gets prescribed for sleep at all

Several antidepressants cause drowsiness as a side effect, and prescribers sometimes use that side effect on purpose, in someone who has trouble sleeping alongside depression, anxiety, or simply persistent insomnia. Trazodone is by far the most common example: it carries no FDA approval for insomnia, yet it is one of the most frequently prescribed sleep aids in the country, used at a fraction of the dose given for depression 1Ref 1Jaffer KY, Chang T, Vanle B, et al. (2017).Trazodone for Insomnia: A Systematic Review.That trazodone is used off-label for insomnia at doses lower than its antidepressant dose, is one of the most commonly prescribed sleep aids, and has modest efficacy evidence with a shortage of high-quality trials..

Off-label means a drug is being used for a purpose outside what it was approved for. It is legal and common, but it also means the manufacturer never had to prove the drug works well for that purpose to a regulator's satisfaction — which is exactly the gap the evidence below is about.

The overlap between mood and sleep is part of why this happens so often. Depression and anxiety frequently travel with insomnia, sometimes causing it and sometimes made worse by it, and a medication that quiets both the racing thoughts of anxiety and the wakefulness of insomnia can look like an efficient choice on paper — one prescription addressing two complaints, at least in theory.

What the evidence says about trazodone for sleep

A systematic review of trazodone for insomnia found modest evidence that it helps people stay asleep, alongside a real shortage of large, high-quality trials given how widely it is used 1Ref 1Jaffer KY, Chang T, Vanle B, et al. (2017).Trazodone for Insomnia: A Systematic Review.That trazodone is used off-label for insomnia at doses lower than its antidepressant dose, is one of the most commonly prescribed sleep aids, and has modest efficacy evidence with a shortage of high-quality trials.. That gap between popularity and proof is not a fringe opinion: the American Academy of Sleep Medicine's own guideline on insomnia drugs weighed the evidence and recommended against using trazodone for chronic insomnia, judging the data too thin to support it 2Ref 2Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.That the AASM guideline recommends against using trazodone for chronic insomnia due to insufficient evidence, and that its formal drug review covers melatonin, trazodone, diphenhydramine, tryptophan, and valerian, not mirtazapine..

A medication can be common practice and still fall short of a guideline recommendation — those are two different questions, and worth keeping separate when a prescription gets discussed.

Where mirtazapine fits, and why its evidence picture is thinner still

Mirtazapine is another antidepressant sometimes prescribed off-label for its sedating effect, structurally unrelated to trazodone but sharing the same underlying logic: a drowsiness side effect borrowed for a second purpose. The AASM guideline that formally reviewed insomnia drugs weighed in on melatonin, trazodone, diphenhydramine, tryptophan, and valerian — mirtazapine is not among the agents it addressed at all 2Ref 2Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017).Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.That the AASM guideline recommends against using trazodone for chronic insomnia due to insufficient evidence, and that its formal drug review covers melatonin, trazodone, diphenhydramine, tryptophan, and valerian, not mirtazapine..

That silence is itself informative. It means the decision to use mirtazapine for sleep rests even more heavily on an individual prescriber's judgment and a person's own response, without the backing of a formal recommendation either for or against it specifically.

Why neither is treated as a first-choice insomnia treatment

The strongest recommendation in chronic insomnia care is not a pill at all. The AASM CBT-I first line recommendation covers multicomponent cognitive behavioral therapy for insomnia, built from components such as sleep restriction therapy and stimulus control, and the same guideline specifically advises against relying on sleep hygiene alone as if it were a treatment 3Ref 3Edinger JD, Arnedt JT, Bertisch SM, et al. (2021).Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.That multicomponent CBT-I carries a strong recommendation for chronic insomnia, and that sleep hygiene alone is recommended against as a standalone treatment.. Sedating antidepressants tend to enter the picture when insomnia sits alongside depression or anxiety that is already being treated, or when other approaches have not resolved the sleep problem, rather than as an opening move.

Sleep hygiene advice — a consistent wake time, limiting caffeine and alcohol, a wind-down routine before bed — has real value for general health, but the evidence behind it is stronger as everyday guidance than as a standalone fix for an insomnia disorder that is already established 4Ref 4Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH (2015).The role of sleep hygiene in promoting public health: A review of empirical evidence.That sleep hygiene evidence is stronger for general population health than as a validated standalone treatment for an established insomnia disorder..

The next-day trade-off worth asking about

Because these drugs work by causing drowsiness broadly rather than targeting sleep-specific chemistry with precision, the same effect that helps someone fall asleep can linger into the next morning for some people. Trazodone grogginess the following day is one of the more common reasons people stop taking it, and it is worth naming directly rather than discovering it by trial and error. Mirtazapine can carry a similar next-day heaviness, plus effects like appetite change that have nothing to do with sleep at all.

How noticeable this is varies enormously from person to person, and often from night to night in the same person, depending on factors like how the dose lines up with bedtime and what else is being taken alongside it. That variability is exactly why an early, honest check-in about how mornings actually feel — foggy, fine, or somewhere in between — matters more than waiting weeks to mention it.

Other drugs borrowed for sleep in the same way

Antidepressants are not the only medications repurposed for their sedating side effects. Quetiapine for insomnia is a similar off-label story from an antipsychotic, and gabapentin for sleep is the same borrowed logic applied to an anticonvulsant — both come with their own distinct evidence gaps and side-effect profiles, separate from anything specific to trazodone or mirtazapine. Melatonin gets reached for even more often, over the counter and without a prescription at all, despite an evidence base that is thinner still for chronic insomnia. None of these were designed from the ground up to treat insomnia; all of them are borrowed tools, which is exactly why the conversation about using one is different from the conversation about a purpose-built sleep medication.

Questions worth raising before starting one of these

Because an antidepressant prescribed for sleep is doing double duty, a few questions tend to clarify what is actually being decided: is this being started mainly for mood, mainly for sleep, or both at once? Is there a plan to reassess it if sleep improves but grogginess becomes its own problem? And has cognitive behavioral therapy for insomnia been discussed as an option, given its strong-recommendation status, or ruled out for a specific reason? None of these questions have a universally right answer — they exist to make sure the reasoning behind the prescription, not just the prescription itself, is something the person taking it understands and agrees with.